Effects of valsartan combined with α-lipoic acid on renal function in patients with diabetic nephropathy: a systematic review and meta-analysis
F Sun, D Jiang, J Cai - BMC endocrine disorders, 2021 - Springer
Background Diabetic nephropathy (DN) is one of the most serious microvascular
complications of diabetes, valsartan and α-lipoic acid alone or in combination has been …
complications of diabetes, valsartan and α-lipoic acid alone or in combination has been …
[PDF][PDF] Curative effects of valsartan alone or combined with alpha-lipoic acid on inflammatory cytokines and renal function in early-stage diabetic kidney disease
Z Jiang, Z Tan, F Meng, X Li - J Coll Physicians Surg Pak, 2019 - jcpsp.pk
The aim of this study was to compare curative effects of valsartan alone or combined with
alpha-lipoic acid (ALA) on inflammatory cytokine indices including hypersensitive C-reactive …
alpha-lipoic acid (ALA) on inflammatory cytokine indices including hypersensitive C-reactive …
Effects of alpha-lipoic acid supplementation on human diabetic nephropathy: A systematic review and meta-analysis
E Vakali, D Rigopoulos, AE Carrillo… - Current diabetes …, 2022 - ingentaconnect.com
Background: Diabetic nephropathy (DN) is kidney dysfunction, which occurs due to elevated
urine albumin excretion rate and reduced glomerular filtration rate. Studies on animals have …
urine albumin excretion rate and reduced glomerular filtration rate. Studies on animals have …
The effects of salvianolate combined with western medicine on diabetic nephropathy: a systematic review and meta-analysis
Y Shen, S Wang, Y Liu, L Ge, L Xia, X Zhang… - Frontiers in …, 2020 - frontiersin.org
Background Salvianolate, a compound mainly composed of salvia magnesium acetate, is
extracted from the Chinese herb Salvia miltiorrhiza. Because of its biological activity, easy …
extracted from the Chinese herb Salvia miltiorrhiza. Because of its biological activity, easy …
[HTML][HTML] Supplementation of conventional anti-diabetic therapy with alpha-lipoic acid prevents early development and progression of diabetic nephropathy
Background Diabetic nephropathy (DN) is the leading cause of end-stage renal disease.
Current pharmacological interventions only retard DN progression. Alpha-lipoic acid (ALA) …
Current pharmacological interventions only retard DN progression. Alpha-lipoic acid (ALA) …
Effect of valsartan on kidney outcomes in people with impaired glucose tolerance
G Currie, MA Bethel, B Holzhauer… - Diabetes, Obesity …, 2017 - Wiley Online Library
Aims To examine the effect of valsartan on kidney outcomes in patients with impaired
glucose tolerance (IGT). Methods In a double‐blind randomized trial, 9306 patients with IGT …
glucose tolerance (IGT). Methods In a double‐blind randomized trial, 9306 patients with IGT …
Comparison of nonalbuminuric and albuminuric diabetic kidney disease among patients with type 2 diabetes: A systematic review and meta-analysis
S Shi, L Ni, L Gao, X Wu - Frontiers in Endocrinology, 2022 - frontiersin.org
Background Diabetic kidney disease (DKD) is one of most common complications of
diabetes. Recently, the classical phenotype of DKD, which is characterized by albuminuria …
diabetes. Recently, the classical phenotype of DKD, which is characterized by albuminuria …
Clinical efficacy of alprostadil combined with α-lipoic acid in the treatment of elderly patients with diabetic nephropathy
Y Hong, J Peng, X Cai, X Zhang, Y Liao, L Lan - Open Medicine, 2017 - degruyter.com
Objective To evaluate the effect and toxicity of alprostadil combined with thioctic acid
injection in the treatment of patients with diabetic nephropathy (DN). Methods Sixty two …
injection in the treatment of patients with diabetic nephropathy (DN). Methods Sixty two …
Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria
M Abe, N Maruyama, K Okada, S Matsumoto… - Hypertension …, 2011 - nature.com
The present study aimed to determine whether either of two calcium channel blockers
affected urinary albumin excretion or urinary levels of 8-hydroxy-2′-deoxyguanosine (8 …
affected urinary albumin excretion or urinary levels of 8-hydroxy-2′-deoxyguanosine (8 …
Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy
N Noori, H Tabibi, F Hosseinpanah… - Int J Vitam Nutr …, 2013 - econtent.hogrefe.com
This study was designed to investigate the effects of combined administration of lipoic acid
and pyridoxine on albuminuria, oxidative stress, blood pressure, serum advanced glycation …
and pyridoxine on albuminuria, oxidative stress, blood pressure, serum advanced glycation …
相关搜索
- meta analysis diabetic nephropathy
- renal function diabetic nephropathy
- meta analysis renal function
- acid in the treatment diabetic nephropathy
- elderly patients diabetic nephropathy
- meta analysis acid supplementation
- kidney outcomes effect of valsartan
- valsartan alone curative effects
- clinical efficacy diabetic nephropathy
- acid in the treatment elderly patients
- glucose tolerance effect of valsartan
- pyridoxine on albuminuria diabetic nephropathy
- western medicine diabetic nephropathy
- end products diabetic nephropathy
- early development diabetic nephropathy
- renal function inflammatory cytokines